Quantcast

Latest Neuroregeneration Stories

2014-08-25 23:01:57

PDL BioPharma President & CEO John McLaughlin to step down. Alachua, FL (PRWEB) August 25, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, reported today that John McLaughlin, President and Chief Executive Officer of PDL BioPharma, Inc. has resigned from AxoGen’s Board of Directors. Mr. McLaughlin joined AxoGen’s Board in 2012 as part of the Revenue Interest Purchase Agreement between AxoGen and PDL. At this...

2014-08-07 15:39:20

Salk Institute Scientists hope to borrow strategy from simpler animals to repair damaged spinal cord nerves in humans Frogs, dogs, whales, snails can all do it, but humans and primates can't. Regrow nerves after an injury, that is—while many animals have this ability, humans don't. But new research from the Salk Institute suggests that a small molecule may be able to convince damaged nerves to grow and effectively rewire circuits. Such a feat could eventually lead to therapies for the...

2014-08-05 23:07:42

Nerve repair company AXGN to participate in investor conference in New York Alachua, FL (PRWEB) August 05, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is scheduled to present at the Wedbush 2014 Life Sciences Management Access Conference on Tuesday, August 12, 2014 at 10:55am (ET) at Le Parker Meridien Hotel in New York City. A live webcast and subsequent archived replay of the Company’s...

2014-08-04 23:01:16

Quarterly Record Revenue of $4.2 Million; Gross Margin expands to 79%. Conference Call Today at 4:30 pm ET. Alachua, FL (PRWEB) August 04, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced record quarterly revenue of $4.21 million for the second quarter ended June 30, 2014, representing growth of 47% as compared to $2.86 million for the second quarter of 2013. The increase in revenue was driven by increased...

2014-07-15 23:05:17

Nerve repair company to announce results and host call for investors. Alachua, FL (PRWEB) July 15, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for the second quarter ended June 30, 2014 on Monday, August 4, 2014 after the close of the markets. The Company will host a conference call and webcast for the investment community on Monday, August 4, 2014 at 4:30 PM ET. Investors within the United...

2014-07-07 10:28:28

Neural Regeneration Research Researchers at the University of Birmingham, UK, led by Dr. Ben Scheven, Dr. Wendy Leadbeater and Ben Mead have discovered that stem cells isolated from the teeth, termed dental pulp stem cells (DPSC), can protect retinal ganglion cells (RGCs) from death following injury and promote regeneration of their axons along the optic nerve. RGC loss is the leading cause of blindness and can arise through traumatic injury or degenerative diseases such as glaucoma....

2014-06-18 23:11:38

Expanded outcomes data from the Ranger® Registry to be presented Alachua, FL (PRWEB) June 18, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, today announced the acceptance of two clinical presentations on the use of Avance® Nerve Graft and a scientific presentation on the use of coaptation aids in nerve repair at the 29th Congress of the Federation of European Societies for Surgery of the Hand (FESSH), June...

2014-06-09 23:07:46

Nerve Repair Company AXGN to participate in investor conference in New York Alachua, FL (PRWEB) June 09, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is scheduled to present at the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 12:30pm (ET) at the Westin New York Grand Central. A live webcast and subsequent archived replay of the Company’s presentation may be accessed...

2014-06-04 23:10:04

$1.9 Million in Grant funding will explore application of novel stem cells and development of branched grafts for complex nerve repair Alachua, FL (PRWEB) June 04, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it would share in the award of two Department of Defense Grants totaling approximately $1.9 million with Brigham and Women’s Hospital in Boston (BWH). The grants, awarded to Principal...

2014-04-28 23:08:35

Company to feature portfolio of products for peripheral nerve repair, protection and regeneration at ACOMS Annual Meeting Alachua, FL (PRWEB) April 28, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it will be highlighting its products at the American College of Oral and Maxillofacial (ACOMS) 35th Annual Scientific Conference and Exhibition, April 27-30 in Las Vegas, Nevada. AxoGen is exhibiting its full...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related